Rigel Pharmaceuticals Inc (RIGL)
1.05
-0.06
(-5.41%)
USD |
NASDAQ |
Apr 18, 16:00
1.06
+0.01
(+0.95%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Financing (Quarterly): 0.486M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.486M |
| September 30, 2023 | -0.869M |
| June 30, 2023 | -0.373M |
| March 31, 2023 | 19.12M |
| December 31, 2022 | -2.096M |
| September 30, 2022 | 5.511M |
| June 30, 2022 | -5.662M |
| March 31, 2022 | 8.797M |
| December 31, 2021 | 1.085M |
| September 30, 2021 | 0.274M |
| June 30, 2021 | 59.22M |
| March 31, 2021 | 2.097M |
| December 31, 2020 | 0.667M |
| September 30, 2020 | 0.052M |
| June 30, 2020 | 10.52M |
| March 31, 2020 | 1.336M |
| December 31, 2019 | 0.694M |
| September 30, 2019 | 9.799M |
| June 30, 2019 | 0.856M |
| March 31, 2019 | 0.016M |
| December 31, 2018 | 1.099M |
| September 30, 2018 | 0.635M |
| June 30, 2018 | 68.15M |
| March 31, 2018 | 2.011M |
| December 31, 2017 | 67.37M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.337M |
| June 30, 2017 | 3.561M |
| March 31, 2017 | 43.42M |
| December 31, 2016 | 2.035M |
| September 30, 2016 | 13.18M |
| June 30, 2016 | 9.963M |
| March 31, 2016 | 0.004M |
| December 31, 2015 | 5.926M |
| September 30, 2015 | 0.098M |
| June 30, 2015 | 1.012M |
| March 31, 2015 | 0.017M |
| December 31, 2014 | 0.48M |
| September 30, 2014 | 0.005M |
| June 30, 2014 | 0.661M |
| March 31, 2014 | 0.024M |
| December 31, 2013 | 0.229M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.822M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 136.52M |
| September 30, 2012 | 1.196M |
| June 30, 2012 | 0.885M |
| March 31, 2012 | 0.488M |
| December 31, 2011 | 0.769M |
| September 30, 2011 | 0.021M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.662M
Minimum
Jun 2022
59.22M
Maximum
Jun 2021
5.869M
Average
0.856M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Nektar Therapeutics | 0.012M |
| Avid Bioservices Inc | 7.40M |
| Stereotaxis Inc | 0.026M |
| Cara Therapeutics Inc | 36.48M |
| Blueprint Medicines Corp | 15.53M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.24M |
| Cash from Investing (Quarterly) | -6.874M |
| Free Cash Flow | -20.74M |
| Free Cash Flow Per Share (Quarterly) | -0.0358 |
| Free Cash Flow to Equity (Quarterly) | -6.183M |
| Free Cash Flow Yield | -11.35% |